期刊文献+

血清及支气管肺泡灌洗液肿瘤标志物测定对肺癌的诊断意义 被引量:5

Clinical significance of determination of tumor markers in serum and bronchoalveolar lavage fluid
下载PDF
导出
摘要 目的探讨支气管肺泡灌洗液(BALF)和血清中肿瘤标志物细胞角蛋白19片段(CYFRA21-1),神经元特异性烯醇化酶(NSE)、癌胚抗原(CEA)含量在肺癌诊断过程中的变化、敏感程度及联合检测的意义。方法选择确诊的肺癌患者45例作为检测组,肺部良性病变患者45例作为对照组。使用酶联免疫吸附(ELISA)方法检测两组患者的BALF和血清中CYFRA21-1、NSE、CEA的含量。结果肺癌患者BALF及血清中CYFRA21-1、NSE、CEA浓度明显高于肺良性病变组(P<0.05),BALF中CYFRA21-1、NSE、CEA均高于血清中含量。结论肺癌患者BALF和血清中CYFRA21-1、NSE、CEA联合检测对肺癌诊断有较高的临床参考价值。 Objective To discuss the significance of CYFRA21 - 1, NSE and CEA in bronchoalveolar lavage fluid (BALF) in diagnosis, pathological type and stage of lung cancer. Methods 45 cases of lung cancer and 45 cases of benign lung diseases were enrolled as study group and control group respectively. Enzyme linked immunosorbent assay was used to detect the level of these three tumor markers in serum and BALF in these two groups. Results Levels of CYFRA21 - 1, NSE and CEA in serum and BALF of patients with lung cancr were higher than those of control group, and the difference was significant ( P 〈 0.05 ). Conclusion Detecting levels of CYFRA21 - 1, NSE and CEA in BALFof patients with lung cancer have important significance in diagnosis of lung cancer.
作者 凌丽
出处 《临床和实验医学杂志》 2009年第8期13-14,共2页 Journal of Clinical and Experimental Medicine
关键词 肺癌 支气管肺泡灌洗液 肿瘤标志物 Lung cancer Bronchoalveolar lavage fluid Tumor markers
  • 相关文献

参考文献6

二级参考文献33

共引文献35

同被引文献45

  • 1黄芳,王香玲,荫斌霞,展淑琴.支气管肺泡灌洗液中3种肿瘤标志物的含量检测及意义[J].第四军医大学学报,2005,26(16):1499-1502. 被引量:2
  • 2杨拴盈,张王刚,孙秀珍,何积银,李雅莉,刘原,张洁,董西林,杨德昌.五种血清肿瘤标志物单个或联合检测在肺癌诊断中作用的初步评价[J].西安交通大学学报(医学版),2005,26(4):352-354. 被引量:16
  • 3Zhang Shaowu, Ning Jie. In bronehoalveolar lavage fluid of combined detection of tumor markers in lung cancer diagnosis [J]. modem Chinese medicine, 2011:18 ( 05): 424-425.
  • 4Haiyan, Liu Hong, Wang Jing, et al. Combined detection of tumor markers in lung cancer diagnosis [J]. Chinese Journal of Gerontology 2012; 22(01 ):600-602.
  • 5Li M, Liu L, Liu Z, et al. The status of KRAS mutations in patients with non-small cell lung cancers from China's Mainland [ J ]. Oncol Rep, 2009,22 ( 5 ) : 1013-1020.
  • 6Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR[ J ]. N Engl J Med, 2010,362 (25) :2380-2388.
  • 7Brandes AA, Franceschi E ,Tosoni A, et al. Epidermal growth factor re- ceptor inhibitors in neuro-oncology: hopes and disappointments [ J ]. Clin Cancer Res,2008,14 (4) :957-960.
  • 8Jang TW, Oak CH, Chang HK, et al. EGFR and KRAS mutations in patients with adenocarcinoma of the lung [ J ]. Korean Intern Med, 2009,24( 1 ) :48-54.
  • 9Huang W, Hu J,Yang DW, et al. Two microRNA panels to discrimi- nate three subtypes of lung carcinoma in bronchial brushing speci- mens[ J ]. Am Respir Crit Care Med ,2012,186 ( 11 ) : 1160-1167.
  • 10Mascaux C, Lacs JF, Anthoine G, et al. Evolution of microRNA ex- pression during human bronchial squamous carcinogenesis [ J ]. Eur Respir,2009,33 (5) :352-359.

引证文献5

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部